Fabryka Narzędzi Medycznych CHIRMED Marcin Dyner Spółka Komandytowa has received funding from the European Union for the implementation of the project “Increasing the Recognition of the CHIRMED Product Brand on Foreign Markets” under the European Funds for a Modern Economy programme, Measure 2.25 Promotion of Innovative SME Brands.
The aim of the project is to increase the recognition and promote the CHIRMED brand on foreign markets and, consequently, to establish new business contacts and sign new contracts resulting in an increase in the company’s export sales.
The project concerns specialised surgical instruments made of stainless steel and titanium, intended for, among others, microsurgery, minimally invasive surgery, cardiac surgery, vascular surgery, neurosurgery, orthopaedics and dentistry, including implantology. The product range includes, among others, forceps, scalpels, vascular clamps, needle holders, scissors, retractors and instruments manufactured according to customers’ specifications.
The project objective will be achieved through participation as an exhibitor in international trade fairs and participation in business missions abroad. Promotional activities will target the markets of China, Germany, India and the United Arab Emirates. The project includes, among others, participation in the China International Medical Equipment Fair (CMEF) in China, MEDICA in Germany, Medical Fair India in India and WHX Dubai in the United Arab Emirates.
As part of the project, CHIRMED will participate as an exhibitor at WHX Dubai in 2027 and 2028. In addition, company representatives will participate in business missions associated with CMEF 2026, MEDICA in 2026–2028, Medical Fair India 2027 and WHX Dubai 2029. During the missions, B2B meetings with potential business partners and presentations of the company’s product range are planned.
The project will benefit employees participating in trade fairs and exhibitions, as well as employees of the export and production departments and employees involved in the implementation of new products.
Ultimately, the company’s customers in Poland and abroad will be able to use the new products.
The implementation of the project will result in increased recognition of the CHIRMED brand in the targeted foreign markets, the establishment of new business contacts and the acquisition of new commercial contracts. These activities are intended to contribute to an increase in the company’s export sales and the further development of CHIRMED’s operations on international markets, while respecting the natural environment and social needs.
Project value: PLN 418,384.99
EU Funds contribution: PLN 225,253.13
Funding agreement No.: FENG.02.25-IP.02-0307/25